Shanghai RAAS Blood Products Co. Ltd. | Ownership
Companies that own Shanghai RAAS Blood Products Co. Ltd.
Shaanxi International Trust Co. Ltd. (Invt Mgmt)
93,126,767
0%
69,499,064
0%
09/30/2017
Minsheng Tonghui Asset Management Co., Ltd.
45,256,840
0%
-2,869,636
0%
09/30/2017
China Investment Corp. (Investment Management)
31,534,560
0%
0
0%
09/30/2017
China Asset Management Co., Ltd.
5,914,135
0%
1,564,884
0%
12/31/2017
Guotai Asset Management Co., Ltd.
4,558,069
0%
-1,050,720
0%
12/31/2017
E Fund Management Co., Ltd.
3,540,134
0%
1,011,640
0%
06/29/2018
Huatai-PineBridge Fund Management Co., Ltd.
2,558,395
0%
676,720
0%
12/31/2017
Harvest Fund Management Co., Ltd.
2,415,068
0%
680,840
0%
07/27/2018
China Merchants Fund Management Co., Ltd.
1,805,509
0%
77,055
0%
12/31/2017
The Vanguard Group, Inc.
1,704,422
0%
0
0%
07/31/2018
| Address |
No. 2009 Wangyuan Road
Shanghai Shanghai 201401
China
|
|
Employees
|
- |
| Website |
http://www.raas-corp.com |
| Updated |
07/08/2019 |
| Shanghai RAAS Blood Products Co., Ltd. engages in the production and sale of blood products. It provides testing services for blood, vaccines, diagnostic reagents, and testing equipment. Its products include human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin. |
